119 related articles for article (PubMed ID: 203884)
1. Therapy of small cell carcinoma of the lung with hexamethylmelamine.
Huang MN; Takita H; Catane H; Yee Chen T
Oncology; 1978; 35(1):29-32. PubMed ID: 203884
[TBL] [Abstract][Full Text] [Related]
2. Hexamethylmelamine as a single agent in the treatment of small-cell carcinoma of the lung.
Goldsweig HG; Edgerton F; Redden CS; Takita H; Garza JG; Bisel HF
Am J Clin Oncol; 1982 Jun; 5(3):267-72. PubMed ID: 6282109
[No Abstract] [Full Text] [Related]
3. Doxorubicin-hexamethylmelamine therapy of small cell carcinoma of the lung.
Dara P; Schultz MJ; Slater LM; Armentrout SA
Cancer; 1981 Nov; 48(9):1944-6. PubMed ID: 6271385
[TBL] [Abstract][Full Text] [Related]
4. A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2.
Wilson WL; Ryzin JV; Weiss AJ; Frelick RW; Moss SE
Oncology; 1975; 31(5-6):293-309. PubMed ID: 174041
[TBL] [Abstract][Full Text] [Related]
5. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
6. cis-Dichlorodiammineplatinum(II) and hexamethylmelamine in the treatment of non-oat cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
Krauss S; Tornyos K; DeSimone P; Lowenbraun S; McKeown J; Solomon A; Sonoda T
Cancer Treat Rep; 1979 Mar; 63(3):391-3. PubMed ID: 106964
[TBL] [Abstract][Full Text] [Related]
7. Hexamethylmelamine (altretamine) in small cell lung cancer (SCLC).
Comis RL
Cancer Treat Rev; 1991 Mar; 18 Suppl A():85-90. PubMed ID: 1646071
[No Abstract] [Full Text] [Related]
8. The role of hexamethylmelamine in advanced ovarian carcinoma treatment.
Weiss RB
Gynecol Oncol; 1981 Oct; 12(2 Pt 1):141-9. PubMed ID: 6795094
[No Abstract] [Full Text] [Related]
9. Hexamethylmelamine, vincristine, and methotrexate chemotherapy in advanced neoplasms.
Longacre D; Donavan M; Paladine W; Cunningham T; Sponzo R
Cancer Treat Rep; 1977 Aug; 61(5):919-22. PubMed ID: 408004
[No Abstract] [Full Text] [Related]
10. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
[No Abstract] [Full Text] [Related]
11. Phase I--II study of hexamethylmelamine plus dibromodulcitol in refractory carcinoma of the breast.
Van Amburg AL; Presant CA; Vélez-García E; Klahr C
Cancer Treat Rep; 1979 Jan; 63(1):141-2. PubMed ID: 105806
[No Abstract] [Full Text] [Related]
12. Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
Joss RA; Brunner KW; Goldhirsch A
Cancer Treat Rep; 1982 Oct; 66(10):1873-4. PubMed ID: 6290051
[No Abstract] [Full Text] [Related]
13. Evaluation of a hexamethylmelamine and 5-fluorouracil combination in the treatment of advanced ovarian carcinoma.
Kardinal CG; Luce JK
Cancer Treat Rep; 1977 Dec; 61(9):1691-3. PubMed ID: 413624
[TBL] [Abstract][Full Text] [Related]
14. Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamine.
Connors TA; Cumber AJ; Ross WC; Clarke SA; Mitchley BC
Cancer Treat Rep; 1977 Aug; 61(5):927-8. PubMed ID: 408005
[No Abstract] [Full Text] [Related]
15. Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
Pisoni MB; Libretti A; Piazza E; Vago G; Scapaticci R; Bianchi C; Tomirotti M; Scanni A; Calzavara MP; Cassani L; Scarpazza G; Marsoni S; Morasca L
Cancer Treat Rep; 1981; 65(7-8):731-2. PubMed ID: 6788372
[No Abstract] [Full Text] [Related]
16. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
DiBella NJ; Nelson RA; Norgard MJ
Oncology; 1975; 32(2):82-5. PubMed ID: 815858
[TBL] [Abstract][Full Text] [Related]
17. Contribution of prednisone to the effectiveness of hexamethylmelamine in multiple myeloma.
Oken MM; Lenhard RE; Tsiatis AA; Glick JH; Silverstein MN
Cancer Treat Rep; 1987 Sep; 71(9):807-11. PubMed ID: 3113729
[TBL] [Abstract][Full Text] [Related]
18. Hexamethylmelamine in adenocarcinoma of the pancreas and liver.
Oldham DS; Wampler GL
Med Pediatr Oncol; 1983; 11(4):297-8. PubMed ID: 6310359
[TBL] [Abstract][Full Text] [Related]
19. Hexamethylmelamine. An evaluation of its role in the therapy of cancer.
Legha SS; Slavik M; Carter SK
Cancer; 1976 Jul; 38(1):27-35. PubMed ID: 820422
[TBL] [Abstract][Full Text] [Related]
20. Hexamethylmelamine in advanced head and neck cancer. A phase II study.
Gad-El-Mawla N; Macdonald JS; Khaled H
Am J Clin Oncol; 1984 Jun; 7(3):205-8. PubMed ID: 6428214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]